The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD
Open accessAbstract
Background Plasma uric acid levels rise in chronic kidney disease (CKD) and may lead to tubular injury, endothelial dysfunction, oxidative stress, and intra-renal inflammation. Whether uric acid levels are associated with kidney failure and death in CKD is unknown. Study Design A prospective, observational, cohort study. Settings & Participants 3885 individuals with CKD stages 2–4 enrolled in the Chronic Renal Insufficiency Cohort (CRIC) between June 2003 and September 2008, and followed up through March 2013. Predictor Baseline serum uric acid levels. Outcomes Kidney failure (initiation of dialysis or transplantation) and all-cause mortality. Results During a median follow-up of 7.9 years, 885 participants progressed to kidney failure, and 789 participants died. After adjustment for demographic, cardiovascular, and kidney-specific covariates, higher levels of uric acid were independently associated with risk of kidney failure in participants with an estimated glomerular filtration rate ≥ 45 mL/min/1.73 m2 (adjusted HR per 1–standard deviation [SD] greater baseline uric acid, 1.40; 95% CI, 1.12–1.75), but not in those with eGFR < 30 mL/min/1.73 m2. There was a nominally higher HR in participants with an eGFR of 30–44 (adjusted HR, 1.13; 95% CI, 0.99–1.29), but this did not reach statistical significance. The relationship between uric acid and all-cause mortality was J-shaped (P = 0.007). Limitations Potential residual confounding through unavailable confounders; lack of follow-up measurements to adjust for changes in uric acid levels over time. Conclusions Uric acid is an independent risk factor for kidney failure in earlier stages of CKD, and has a ‘J-shaped’ relationship with all-cause mortality in CKD. Adequately powered randomized, placebo-controlled trials in CKD are needed to test whether urate lowering may prove to be an effective approach to prevent complications and progression of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Howard, S. C., Jones, D. P., & Pui, C.-H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0904569 · Cited by 1,044
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Corry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f240bf · Cited by 751
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Cited by
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
Kammarchedu, V., Butler, D., & Ebrahimi, A. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340447 · Cited by 79
Metadata
- Authors
- Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T., & Waikar, S. S.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 71
- Issue
- 3
- Pages
- 362-370
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2767610685
- Cited by
- 306
- References
- 48
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. https://app.cochat.ai/papers/10.1053/j.ajkd.2017.08.017
- The paper
- Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T., & Waikar, S. S. (2018). Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2017.08.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.